QuantOmics

NSERC CREATE in AI-Driven Quantum Sensing and Genomics for Precision Therapeutics

Training Canada’s next generation of interdisciplinary leaders at the convergence of quantum biosensing, computational genomics, and artificial intelligence — from sensor to clinic.

Apply Now Explore the Program

A consortium of 6 universities · 11 co-applicants · 93 trainees

What is QuantOmics?

The NSERC CREATE in AI-Driven Quantum Sensing and Genomics for Precision Therapeutics (QuantOmics) is Canada’s first integrated training pipeline bridging quantum nanotechnology, genomic data science, and AI-driven medicine.

A consortium of six research-intensive universities — Toronto Metropolitan University, McGill, Queen’s, Université Laval, University of Saskatchewan, and University of Toronto — together with a cross-sectoral network of industry and clinical partners, will train 93 highly qualified personnel over six years to be fluent across all three domains.

Our driving philosophy: a QuantOmics graduate can speak the language of hardware engineers, molecular biologists, and AI developers simultaneously — making them invaluable as integrators and leaders in Canada’s emerging quantum-biomedical economy.

Three Interconnected Research Streams

An integrated pipeline — from molecule to medicine

Stream 1: Quantum Probe Design & Fabrication

Engineering next-generation quantum biosensors using NV-center diamond probes, quantum-dot nanoparticles, spin-based magnetometry, and CMOS/MEMS integration. Trainees build ultra-sensitive devices capable of detecting biomarkers at the attomolar level.

Stream 2: Genomics Signal Integration

Converting raw quantum sensor data into high-fidelity multi-omic datasets. Trainees build computational pipelines fusing nanopore sequencing, methylation maps, EHR features, and multi-omic data using reproducible workflow tools.

Stream 3: AI-Powered Therapeutic Design

Building predictive AI models to guide rational design of next-generation personalized therapeutics and vaccines. Projects span generative AI for drug design, neoantigen prediction, and multimodal fusion for cancer diagnostics.

93
Trainees over 6 years
(UG · MSc · PhD · PDF)
6
Partner universities
across Canada
11
Co-applicants including
5 Canada Research Chairs
8
Industry & clinical
partner organizations

A Unique Training Experience

Going far beyond a traditional graduate degree

QuantOmics equips trainees with technical depth and professional breadth through a suite of purpose-built learning experiences:

ComponentDescription
🔬 5 Specialized CoursesFrom quantum nanotechnology to responsible AI, building a shared cross-disciplinary vocabulary
🧪 Multimodal-Omics Bootcamp3-week intensive: building full sensor-to-insight analysis pipelines
🤝 Mentorship TrioEvery graduate trainee paired with a primary supervisor, cross-stream co-supervisor, and industry advisor
🏭 Industry & Lab InternshipsMandatory mobility placements (6–8 weeks) at partner labs or companies
🏆 Annual Vaccine Design ChallengeInterdisciplinary team hackathon solving real vaccine design problems
🎓 Symposiums & Job FairsTriennial national symposium with concurrent job fair and recruiter networking

Explore the Full Training Program →

Research Team

Faculty from across Canada

Principal Investigator

Naimul Khan

Principal Investigator & Program Director

Co-Applicants

Brenda Andrews

Tier 1 CRC in Systems Genetics and Cell Biology, UofT

Jacques Corbeil

Professor, Université Laval · MILA Member

Stefania Impellizzeri

Jet Ice Research Chair in Sustainable Materials Chemistry, TMU

Sara Mahshid

Associate Professor, McGill University

Shayan Rayan

Assistant Professor, University of Saskatchewan

Harry Ruda

Stanley Meek Chair in Advanced Nanotechnology, University of Toronto

Amber Simpson

Tier 2 CRC in Biomedical Computing and Informatics, Queen’s University

Brett Trost

Assistant Professor, UofT · Scientist, SickKids

Virgilio Valente

Assistant Professor, Toronto Metropolitan University

Upcoming Events

Our University Consortium

QuantOmics brings together world-class researchers from six Canadian universities:

Toronto Metropolitan University · McGill University · Queen’s University · Université Laval · University of Saskatchewan · University of Toronto

Supported by a cross-sectoral network of industry and clinical partners including C2MI, Epiloid Biotech, Terry Fox Research Institute, Ontario Genomics, Klick Health, Alimentiv, Novavax, and others.

View All Partners →

Contact Us

Have questions about the program, applications, or partnership opportunities? We’d love to hear from you.